title: Involvement of ecto-ATPase and extracellular ATP in polymorphonuclear granulocyte-endothelial interactions.
abstract: The adhesion of human polymorphonuclear granulocytes (PMN) with confluent human endothelial cells (line EAhy926) and with solid substrate coated by collagen and fibronectin (Fn) was studied by phase contrast microscopy and by the measurement of myeloperoxidase activity. The ecto-ATPase inhibitors suramin and Reactive Blue 2 (RB2) more than doubled the adhesion of PMN to endothelial cells. The cells hydrolyzed added ATP and this reaction was inhibited by suramin and RB2. The degree of ATP hydrolysis during PMN adherence depended on solid substrata and decreased in the order: non-stimulated endothelial cells, TNF-stimulated endothelial cells, collagen-coated surface, Fn-coated surface. In the same order adherence increased. The endogenous level of extracellular ATP in the PMN-endothelial coculture was around 25 nM. We conclude that PMN-endothelial adhesion is counteracted by an ecto-ATPase or by ATP receptors with ATPase activity. Such interactions may play a role in PMN rolling and diapedesis as well as in the pathophysiology of PMN activation by an anergic endothelium.
authors.affiliation: A.N. Belozersky Institute of Physico-Chemical Biology, Moscow State University, Russia. sudina@bk408.genebee.msu.su
authors.forename: G F
authors.initials: GF
authors.lastname: Sud'ina
authors.forename: O K
authors.initials: OK
authors.lastname: Mirzoeva
authors.forename: S I
authors.initials: SI
authors.lastname: Galkina
authors.forename: M A
authors.initials: MA
authors.lastname: Pushkareva
authors.forename: V
authors.initials: V
authors.lastname: Ullrich
mesh_terms: D000251:Adenosine Triphosphatases / Q000037:antagonists & inhibitors* / Q000502:physiology; D000255:Adenosine Triphosphate / Q000037:antagonists & inhibitors* / Q000502:physiology; D000969:Antinematodal Agents / Q000494:pharmacology; D002448:Cell Adhesion / Q000187:drug effects*; D002450:Cell Communication / Q000187:drug effects; D003094:Collagen / Q000502:physiology; D004727:Endothelium / Q000187:drug effects / Q000502:physiology; D004791:Enzyme Inhibitors / Q000494:pharmacology*; D006098:Granulocytes / Q000187:drug effects* / Q000502:physiology; D006801:Humans; D006868:Hydrolysis; D009840:Oligomycins / Q000494:pharmacology; D010042:Ouabain / Q000494:pharmacology; D013498:Suramin / Q000494:pharmacology
chemical_list: D000969:Antinematodal Agents; D004791:Enzyme Inhibitors; D009840:Oligomycins; D010042:Ouabain; D013498:Suramin; D000255:Adenosine Triphosphate; D003094:Collagen; D000251:Adenosine Triphosphatases; C027201:ectoATPase